Hennion & Walsh Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.81M | Sell |
|
|||||
|
2025
Q2 | $3.02M | Buy |
|
|||||
|
2025
Q1 | $2.18M | Buy |
|
|||||
|
2024
Q4 | $1.9M | Buy |
|
|||||
|
2024
Q3 | $1.47M | Sell |
|
|||||
|
2024
Q2 | $1.67M | Sell |
|
|||||
|
2024
Q1 | $2.64M | Buy |
|
|||||
|
2023
Q4 | $3.6M | Sell |
|
|||||
|
2023
Q3 | $2.92M | Sell |
|
|||||
|
2023
Q2 | $3.62M | Sell |
|
|||||
|
2023
Q1 | $3.99M | Buy |
|
|||||
|
2022
Q4 | $3.32M | Buy |
|
|||||
|
2022
Q3 | $3.27M | Buy |
|
|||||
|
2022
Q2 | $2.79M | Sell |
|
|||||
|
2022
Q1 | $5.12M | Buy |
|
|||||
|
2021
Q4 | $4.44M | Buy |
|
|||||
|
2021
Q3 | $3.01M | Buy |
|
|||||
|
2021
Q2 | $4.1M | Buy |
|
|||||
|
2021
Q1 | $4.11M | Buy |
|